4//SEC Filing
Dyrness Albert D. 4
Accession 0001493152-22-009486
CIK 0001106838other
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 4:30 PM ET
Size
5.0 KB
Accession
0001493152-22-009486
Insider Transaction Report
Form 4
Dyrness Albert D.
Director
Transactions
- Award
Common Stock
2021-12-15+14,152→ 27,123 total
Footnotes (1)
- [F1]On December 15, 2021, the Reporting Person was granted 14,152 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 100% of the restricted stock units on January 1, 2023.
Documents
Issuer
Sonnet BioTherapeutics Holdings, Inc.
CIK 0001106838
Entity typeother
Related Parties
1- filerCIK 0001664801
Filing Metadata
- Form type
- 4
- Filed
- Apr 7, 8:00 PM ET
- Accepted
- Apr 8, 4:30 PM ET
- Size
- 5.0 KB